SlideShare a Scribd company logo
Presented by: Dr. Nidhi Varma
 Blood collection is the most important and
essential function of blood transfusion services
and accordingly its organization should be given
due attention.
 The source of blood transfusion is donors.
There are four types of blood donors:
 Voluntary non-remunerated donors
 Replacement or relative donors
 Professional or commercial donors
 Autologous donors
 These are the people who donate blood without
any pressure and monetary benefit for unknown
patients. Such donors are important for blood
transfusion services because:
• They belong to the low risk category
• They are mostly willing to be on the panel of
regular blood donors.
• They mostly respond to appeals during
emergencies.
 These are members of a family/friend who donate
their blood in replacement of the blood needs of
the particular patient.
 Such donors come forward mostly for specific
purpose of helping their relative/friend.
 At times, donors request that their blood should
be given to specific patients. Such donations are
called Directed Donations. It is advisable to avoid
such donations, except in certain circumstances.
 These are people who receive direct or indirect
monetary benefit for the blood they donate.
 These blood donors often conceal the truth about
their illness, previous donations and personal life,
thus contributing to unsafe blood supply.
 These also donate blood more frequently than
recommended and thus supply substandard units
of blood which may give little or no benefit to the
recipient.
 Autologous donation is the collection of blood
from a patient in advance of scheduled surgery for
transfusion during or after the procedure to
compensate for the expected blood loss.
 It prevents immune reactions and transmission of
blood-borne pathogens from allogenic donors.
 However it is not completely free from risk as
bacterial contamination could still occur.
 The blood transfusion services or blood bank has a
responsibility to ensure the protection of the blood
donor and transfusion recipient.
 Accordingly the donor should be selected on the
basis of following two important things:
• Medical history
• Preliminary health check
 Before taking medical history, it is important to
inform all potential donors about health
conditions and high risk behaviours which make
them unsuitable to donate blood. The information
should be displayed in the form of posters in
various languages.
 After preliminary information about blood
donation, if the donor appears healthy, the Blood
Donor Consent Form (questionnaire) is filled by
donor himself or the donor clinic staff
(interviewer) and evaluated for accepting,
temporary deferral or rejection by medical officer.
Some important points covered in the history are:
 If the donor is feeling well today
 Did he eat something in the last 4 hours
 Did he sleep well last night
 History of intake of alcohol, drugs like aspirin,
steroids or any vaccinations in the past 72 hours.
 History of unexplained weight loss, continuous low
grade fever, swollen glands or persistent diarrhoea
in the past 6 months.
 History of ear piercing, dental extraction or
tattooing in the past 6 months.
 History of conditions like heart diseases, lung
disease, chronic kidney disease, chronic liver
disease, STDs, jaundice, abnormal bleeding
tendencies, cancer, diabetes, tuberculosis, malaria,
typhoid, etc.
 History of major or minor surgery or blood
transfusion in the past 6 months.
 For women donors, it is important to ask history
of pregnancy, any abortions in the last 3 months
or children less than 1 yr old.
 Helps to collect same information systematically
from each donor.
 Donor clinical staff does not forget to ask some
important questions.
 It helps donor clinic staff to make quick
assessment whether to accept, temporarily defer
or permanently reject the donor.
 It is important to make preliminary health check
up of the donor before donation, in order to make
an assessment of their health status and not solely
depend on what donors tell in their medical
history.
 The following parameters should be checked each
time the donor comes to donate blood.
General appearance The donor should be in good health
Age Donors should be between the age of 18-60 years
Weight
Donors weighing 45 kg can give 350 ml of blood
and those weighing 55 kg and above may give 450
ml of blood
Blood pressure
The systolic blood pressure should be between
100-180 mm Hg and diastolic blood pressure
should be between 50-100 mm of Hg
Pulse
The pulse should be between 60-100 beats per
minute and regular
Temperature Oral temperature should not exceed 37.5°C
Physical assessment of the
donor
Look for any skin rashes and swollen glands
Scar of needle pricks at venipuncture site might
indicate either drug addiction or frequent blood
donations in professional donors
Hemoglobin estimation Hb should not be less than 12.5 gm/dl
 Heart disease
 Kidney disease
 Epilepsy
 Anemia
 Ulcers
 Circulatory problems
 Diabetes
 Menstrual problems (excessive bleeding)
 Pregnancy
 Breast feeding
 Similarly, it would be harmful for the recipient, if
donor is having history of any of following
diseases -
• Hepatitis
• Sexually transmitted disease
• Recent vaccination
• Active tuberculosis
• Malaria
• HIV/AIDS
• Lung disease
• Recent history of blood transfusion or surgery
• Unexplained weight loss
CONDITIONS FOR DEFERRAL PERIOD OF DEFERRAL
History of blood transfusion 6 months
Minor surgery 3 months
Major surgery 6 months
Alcoholism Till intoxicated
Typhoid 6 months after recovery
History of malaria & duly treated
3 months (endemic)
6 months (non endemic)
History of hepatitis in family or close
contact
6 months
CONDITIONS FOR DEFERRAL PERIOD OF DEFERRAL
Immunizations (cholera, typhoid,
diphtheria, tetanus, plague, etc)
24 hours after symptom free
Rabies vaccination 1 year after bite
Acute nephritis 6 months after recovery
Breast feeding 6 months after delivery
Abortion 6 months
Tattoo 6 months
DRUGS PERIOD OF DEFERRAL
Aspirin 36-48 hrs
Isotretinoin 1 month after last dose
Finasteride 1 month after last dose
Acitretin 3 years after last dose
Hepatitis B Ig 12 months
Bovine insulin Permanent deferral
 Antibiotics
 Topical steroid preparations for skin lesions not
present at venipuncture sites.
 Blood pressure medications. However, donor
should be free from side effects of anti-
hypertensives, especially postural hypotension.
 Bronchodilators and decongestants
 Oral hypoglycemic agents
 Oral contraceptives, mild analgesics, vitamins and
replacement hormones.
Hepatitis B vaccine 7 days
Oral Typhoid, Oral Polio,
Yellow Fever
2 weeks
Chicken pox, MMR
(measles, mumps, rubella)
4 weeks
Smallpox At least 21 days
 Cancer
 Heart disease
 Abnormal bleeding tendencies
 Unexplained weight loss
 Diabetes controlled on insulin
 Hepatitis B infection
 Chronic nephritis
 Signs and symptoms suggestive of AIDS
 Liver disease
 Tuberculosis
 Polycythemia Vera
 Asthma
 Epilepsy
 Leprosy
 Schizophrenia
 Endocrine disorders
 Finally I would like to conclude my presentation
with a note that blood donation could give as well
as take lives.
 Hence it is essentially important to follow all the
rules and precautions to ensure safety of both the
donor and the recipient.
 Also it is important that voluntary non
remunerated blood donations should be
promoted, accepted and practised for safe blood
supply.
DONOR SELECTION AND DONOR DEFERRAL.pptx

More Related Content

What's hot

blood grouping.ppt
blood grouping.pptblood grouping.ppt
blood grouping.ppt
rohitshrivastava97
 
Forward and reverse grouping by Negash Alamin
Forward and reverse grouping  by Negash AlaminForward and reverse grouping  by Negash Alamin
Forward and reverse grouping by Negash Alamin
Negash Alamin
 
Blood component preparation
Blood component preparationBlood component preparation
Blood component preparation
SUNIL KUMAR PEDDANA
 
Abo blood grouping
Abo blood groupingAbo blood grouping
Abo blood grouping
Tagore medical College
 
Blood component preparation blood banking
Blood component preparation blood bankingBlood component preparation blood banking
Blood component preparation blood banking
Appy Akshay Agarwal
 
Compatibility testing
Compatibility testingCompatibility testing
Compatibility testing
KalaivaniGanapathy
 
Blood donor selection
Blood donor selectionBlood donor selection
Blood donor selection
tareq chowdhury
 
Blood component & its QC
Blood component & its QCBlood component & its QC
Blood component & its QC
Asif Zeb
 
Automation in blood banking
Automation in blood bankingAutomation in blood banking
Automation in blood banking
Shreya D Prabhu
 
Abo blood group system
Abo blood group systemAbo blood group system
Abo blood group system
SUNIL KUMAR PEDDANA
 
Quality and blood bank
Quality and blood bankQuality and blood bank
Quality and blood bank
Hoda Faramawy
 
Bone marrow aspirate&biopsy preparation
Bone marrow aspirate&biopsy preparationBone marrow aspirate&biopsy preparation
Bone marrow aspirate&biopsy preparation
Malak Salam
 
donor selection criteria
donor selection criteriadonor selection criteria
donor selection criteria
MLT LECTURES BY TANVEER TARA
 
Blood component, sample collection, storage, preservation
Blood component, sample collection, storage, preservationBlood component, sample collection, storage, preservation
Blood component, sample collection, storage, preservation
Nityanand Upadhyay
 
COOMBS TEST.pptx
COOMBS TEST.pptxCOOMBS TEST.pptx
COOMBS TEST.pptx
JoshuaKweka
 
APTT.pptx
APTT.pptxAPTT.pptx
APTT.pptx
rajexh777
 
COOMB'S TEST.pptx
COOMB'S TEST.pptxCOOMB'S TEST.pptx
COOMB'S TEST.pptx
ArpitaChandra12
 
Quality Assurance in Hematology laboratory
Quality Assurance in Hematology laboratoryQuality Assurance in Hematology laboratory
Quality Assurance in Hematology laboratory
Mohammed Abdalla Elhassan
 
Pcv
PcvPcv

What's hot (20)

blood grouping.ppt
blood grouping.pptblood grouping.ppt
blood grouping.ppt
 
Forward and reverse grouping by Negash Alamin
Forward and reverse grouping  by Negash AlaminForward and reverse grouping  by Negash Alamin
Forward and reverse grouping by Negash Alamin
 
Blood component preparation
Blood component preparationBlood component preparation
Blood component preparation
 
Abo blood grouping
Abo blood groupingAbo blood grouping
Abo blood grouping
 
Blood component preparation blood banking
Blood component preparation blood bankingBlood component preparation blood banking
Blood component preparation blood banking
 
Compatibility testing
Compatibility testingCompatibility testing
Compatibility testing
 
Blood donor selection
Blood donor selectionBlood donor selection
Blood donor selection
 
Blood component & its QC
Blood component & its QCBlood component & its QC
Blood component & its QC
 
Automation in blood banking
Automation in blood bankingAutomation in blood banking
Automation in blood banking
 
Abo blood group system
Abo blood group systemAbo blood group system
Abo blood group system
 
Quality and blood bank
Quality and blood bankQuality and blood bank
Quality and blood bank
 
Bone marrow aspirate&biopsy preparation
Bone marrow aspirate&biopsy preparationBone marrow aspirate&biopsy preparation
Bone marrow aspirate&biopsy preparation
 
donor selection criteria
donor selection criteriadonor selection criteria
donor selection criteria
 
Blood component, sample collection, storage, preservation
Blood component, sample collection, storage, preservationBlood component, sample collection, storage, preservation
Blood component, sample collection, storage, preservation
 
COOMBS TEST.pptx
COOMBS TEST.pptxCOOMBS TEST.pptx
COOMBS TEST.pptx
 
APTT.pptx
APTT.pptxAPTT.pptx
APTT.pptx
 
COOMB'S TEST.pptx
COOMB'S TEST.pptxCOOMB'S TEST.pptx
COOMB'S TEST.pptx
 
Quality Assurance in Hematology laboratory
Quality Assurance in Hematology laboratoryQuality Assurance in Hematology laboratory
Quality Assurance in Hematology laboratory
 
Pcv
PcvPcv
Pcv
 
Pcv
PcvPcv
Pcv
 

Similar to DONOR SELECTION AND DONOR DEFERRAL.pptx

donor selection criteria
donor selection criteriadonor selection criteria
donor selection criteria
MLT LECTURES BY TANVEER TARA
 
Donor selection and type ss
Donor selection and type ssDonor selection and type ss
Donor selection and type ss
Dr Shahida Baloch
 
Blood donor selection guidelines 2017
Blood donor selection guidelines 2017Blood donor selection guidelines 2017
Blood donor selection guidelines 2017
akshaya tomar
 
Blood bank
Blood bankBlood bank
Blood Donation
Blood DonationBlood Donation
Blood Donation
ReenaSharma120
 
Blood donation facts
Blood donation factsBlood donation facts
Blood donation facts
saicom
 
Bonor selection criteria 1
Bonor selection criteria 1Bonor selection criteria 1
Bonor selection criteria 1
Asif Zeb
 
Blood donation facts
Blood donation factsBlood donation facts
Blood donation facts
saicom
 
Blood donation facts
Blood donation factsBlood donation facts
Blood donation facts
saicom
 
Blood donation ss
Blood donation ssBlood donation ss
Blood donation ss
Dr Shahida Baloch
 
Blood donation
Blood donationBlood donation
Blood donation
sneethusunny
 
RBITC Blood donation ppt 2013 b
RBITC Blood donation ppt 2013 bRBITC Blood donation ppt 2013 b
RBITC Blood donation ppt 2013 b
Sanjay Swamy
 
2016 education at recruitment
2016 education at recruitment2016 education at recruitment
2016 education at recruitmentMagda Silva
 
Blood Donation presntn by ME.ppt
Blood Donation presntn by ME.pptBlood Donation presntn by ME.ppt
Blood Donation presntn by ME.ppt
ssuser314b69
 
Blood Donation – A social Responsibility
Blood Donation – A social ResponsibilityBlood Donation – A social Responsibility
Blood Donation – A social ResponsibilityBISWAROOP BISWAS
 
screening of blood donation.pptx
screening of blood donation.pptxscreening of blood donation.pptx
screening of blood donation.pptx
Najah54
 
Blood donation
Blood donationBlood donation
Blood donation
Simi Ahuja
 

Similar to DONOR SELECTION AND DONOR DEFERRAL.pptx (20)

donor selection criteria
donor selection criteriadonor selection criteria
donor selection criteria
 
Blood donation
Blood donationBlood donation
Blood donation
 
Donor selection and type ss
Donor selection and type ssDonor selection and type ss
Donor selection and type ss
 
Blood donor selection guidelines 2017
Blood donor selection guidelines 2017Blood donor selection guidelines 2017
Blood donor selection guidelines 2017
 
Blood bank
Blood bankBlood bank
Blood bank
 
Blood Donation
Blood DonationBlood Donation
Blood Donation
 
Blood donation facts
Blood donation factsBlood donation facts
Blood donation facts
 
Bonor selection criteria 1
Bonor selection criteria 1Bonor selection criteria 1
Bonor selection criteria 1
 
Blood donation facts
Blood donation factsBlood donation facts
Blood donation facts
 
Blood donation facts
Blood donation factsBlood donation facts
Blood donation facts
 
Blood donation ss
Blood donation ssBlood donation ss
Blood donation ss
 
Blood donation
Blood donationBlood donation
Blood donation
 
RBITC Blood donation ppt 2013 b
RBITC Blood donation ppt 2013 bRBITC Blood donation ppt 2013 b
RBITC Blood donation ppt 2013 b
 
Blood donation
Blood donationBlood donation
Blood donation
 
Blood donation 2014
Blood donation 2014Blood donation 2014
Blood donation 2014
 
2016 education at recruitment
2016 education at recruitment2016 education at recruitment
2016 education at recruitment
 
Blood Donation presntn by ME.ppt
Blood Donation presntn by ME.pptBlood Donation presntn by ME.ppt
Blood Donation presntn by ME.ppt
 
Blood Donation – A social Responsibility
Blood Donation – A social ResponsibilityBlood Donation – A social Responsibility
Blood Donation – A social Responsibility
 
screening of blood donation.pptx
screening of blood donation.pptxscreening of blood donation.pptx
screening of blood donation.pptx
 
Blood donation
Blood donationBlood donation
Blood donation
 

More from Drmustafa Ali

Autoimmunity.ppt
Autoimmunity.pptAutoimmunity.ppt
Autoimmunity.ppt
Drmustafa Ali
 
Adaptive immunity.ppt
Adaptive immunity.pptAdaptive immunity.ppt
Adaptive immunity.ppt
Drmustafa Ali
 
acute lymphoblastic leukemia.pptx
acute lymphoblastic leukemia.pptxacute lymphoblastic leukemia.pptx
acute lymphoblastic leukemia.pptx
Drmustafa Ali
 
BLOOD COMPONENT PREPARATION AND THERAPY.pptx
BLOOD COMPONENT PREPARATION AND THERAPY.pptxBLOOD COMPONENT PREPARATION AND THERAPY.pptx
BLOOD COMPONENT PREPARATION AND THERAPY.pptx
Drmustafa Ali
 
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptxMULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
Drmustafa Ali
 
stains.ppt
stains.pptstains.ppt
stains.ppt
Drmustafa Ali
 
PAS and AFB.ppt
PAS and AFB.pptPAS and AFB.ppt
PAS and AFB.ppt
Drmustafa Ali
 
Glycosylated Hb.ppt
Glycosylated Hb.pptGlycosylated Hb.ppt
Glycosylated Hb.ppt
Drmustafa Ali
 
fISH.pptx
fISH.pptxfISH.pptx
fISH.pptx
Drmustafa Ali
 
ELECTROPHORESIS.pptx
ELECTROPHORESIS.pptxELECTROPHORESIS.pptx
ELECTROPHORESIS.pptx
Drmustafa Ali
 
ELISA.ppt
ELISA.pptELISA.ppt
ELISA.ppt
Drmustafa Ali
 
Blood-groups.ppt
Blood-groups.pptBlood-groups.ppt
Blood-groups.ppt
Drmustafa Ali
 
01.02 ambiguous genitalia CASE PRESENTATION.ppt
01.02 ambiguous genitalia CASE PRESENTATION.ppt01.02 ambiguous genitalia CASE PRESENTATION.ppt
01.02 ambiguous genitalia CASE PRESENTATION.ppt
Drmustafa Ali
 
CVC lung liver and spleen.pptx
CVC lung liver and spleen.pptxCVC lung liver and spleen.pptx
CVC lung liver and spleen.pptx
Drmustafa Ali
 
cell injury apotosis necrosis.pptx
cell injury apotosis necrosis.pptxcell injury apotosis necrosis.pptx
cell injury apotosis necrosis.pptx
Drmustafa Ali
 
Apoptosis.pptx
Apoptosis.pptxApoptosis.pptx
Apoptosis.pptx
Drmustafa Ali
 
Blood-groups.ppt
Blood-groups.pptBlood-groups.ppt
Blood-groups.ppt
Drmustafa Ali
 
Chemical mediators of inflammation.pptx
Chemical mediators of inflammation.pptxChemical mediators of inflammation.pptx
Chemical mediators of inflammation.pptx
Drmustafa Ali
 
BM failure syndrome.pptx
BM failure syndrome.pptxBM failure syndrome.pptx
BM failure syndrome.pptx
Drmustafa Ali
 
Path_MCQ.ppt
Path_MCQ.pptPath_MCQ.ppt
Path_MCQ.ppt
Drmustafa Ali
 

More from Drmustafa Ali (20)

Autoimmunity.ppt
Autoimmunity.pptAutoimmunity.ppt
Autoimmunity.ppt
 
Adaptive immunity.ppt
Adaptive immunity.pptAdaptive immunity.ppt
Adaptive immunity.ppt
 
acute lymphoblastic leukemia.pptx
acute lymphoblastic leukemia.pptxacute lymphoblastic leukemia.pptx
acute lymphoblastic leukemia.pptx
 
BLOOD COMPONENT PREPARATION AND THERAPY.pptx
BLOOD COMPONENT PREPARATION AND THERAPY.pptxBLOOD COMPONENT PREPARATION AND THERAPY.pptx
BLOOD COMPONENT PREPARATION AND THERAPY.pptx
 
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptxMULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
 
stains.ppt
stains.pptstains.ppt
stains.ppt
 
PAS and AFB.ppt
PAS and AFB.pptPAS and AFB.ppt
PAS and AFB.ppt
 
Glycosylated Hb.ppt
Glycosylated Hb.pptGlycosylated Hb.ppt
Glycosylated Hb.ppt
 
fISH.pptx
fISH.pptxfISH.pptx
fISH.pptx
 
ELECTROPHORESIS.pptx
ELECTROPHORESIS.pptxELECTROPHORESIS.pptx
ELECTROPHORESIS.pptx
 
ELISA.ppt
ELISA.pptELISA.ppt
ELISA.ppt
 
Blood-groups.ppt
Blood-groups.pptBlood-groups.ppt
Blood-groups.ppt
 
01.02 ambiguous genitalia CASE PRESENTATION.ppt
01.02 ambiguous genitalia CASE PRESENTATION.ppt01.02 ambiguous genitalia CASE PRESENTATION.ppt
01.02 ambiguous genitalia CASE PRESENTATION.ppt
 
CVC lung liver and spleen.pptx
CVC lung liver and spleen.pptxCVC lung liver and spleen.pptx
CVC lung liver and spleen.pptx
 
cell injury apotosis necrosis.pptx
cell injury apotosis necrosis.pptxcell injury apotosis necrosis.pptx
cell injury apotosis necrosis.pptx
 
Apoptosis.pptx
Apoptosis.pptxApoptosis.pptx
Apoptosis.pptx
 
Blood-groups.ppt
Blood-groups.pptBlood-groups.ppt
Blood-groups.ppt
 
Chemical mediators of inflammation.pptx
Chemical mediators of inflammation.pptxChemical mediators of inflammation.pptx
Chemical mediators of inflammation.pptx
 
BM failure syndrome.pptx
BM failure syndrome.pptxBM failure syndrome.pptx
BM failure syndrome.pptx
 
Path_MCQ.ppt
Path_MCQ.pptPath_MCQ.ppt
Path_MCQ.ppt
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 

Recently uploaded (20)

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 

DONOR SELECTION AND DONOR DEFERRAL.pptx

  • 1. Presented by: Dr. Nidhi Varma
  • 2.  Blood collection is the most important and essential function of blood transfusion services and accordingly its organization should be given due attention.  The source of blood transfusion is donors.
  • 3. There are four types of blood donors:  Voluntary non-remunerated donors  Replacement or relative donors  Professional or commercial donors  Autologous donors
  • 4.  These are the people who donate blood without any pressure and monetary benefit for unknown patients. Such donors are important for blood transfusion services because: • They belong to the low risk category • They are mostly willing to be on the panel of regular blood donors. • They mostly respond to appeals during emergencies.
  • 5.  These are members of a family/friend who donate their blood in replacement of the blood needs of the particular patient.  Such donors come forward mostly for specific purpose of helping their relative/friend.  At times, donors request that their blood should be given to specific patients. Such donations are called Directed Donations. It is advisable to avoid such donations, except in certain circumstances.
  • 6.  These are people who receive direct or indirect monetary benefit for the blood they donate.  These blood donors often conceal the truth about their illness, previous donations and personal life, thus contributing to unsafe blood supply.  These also donate blood more frequently than recommended and thus supply substandard units of blood which may give little or no benefit to the recipient.
  • 7.  Autologous donation is the collection of blood from a patient in advance of scheduled surgery for transfusion during or after the procedure to compensate for the expected blood loss.  It prevents immune reactions and transmission of blood-borne pathogens from allogenic donors.  However it is not completely free from risk as bacterial contamination could still occur.
  • 8.  The blood transfusion services or blood bank has a responsibility to ensure the protection of the blood donor and transfusion recipient.  Accordingly the donor should be selected on the basis of following two important things: • Medical history • Preliminary health check
  • 9.  Before taking medical history, it is important to inform all potential donors about health conditions and high risk behaviours which make them unsuitable to donate blood. The information should be displayed in the form of posters in various languages.  After preliminary information about blood donation, if the donor appears healthy, the Blood Donor Consent Form (questionnaire) is filled by donor himself or the donor clinic staff (interviewer) and evaluated for accepting, temporary deferral or rejection by medical officer.
  • 10.
  • 11. Some important points covered in the history are:  If the donor is feeling well today  Did he eat something in the last 4 hours  Did he sleep well last night  History of intake of alcohol, drugs like aspirin, steroids or any vaccinations in the past 72 hours.  History of unexplained weight loss, continuous low grade fever, swollen glands or persistent diarrhoea in the past 6 months.  History of ear piercing, dental extraction or tattooing in the past 6 months.
  • 12.  History of conditions like heart diseases, lung disease, chronic kidney disease, chronic liver disease, STDs, jaundice, abnormal bleeding tendencies, cancer, diabetes, tuberculosis, malaria, typhoid, etc.  History of major or minor surgery or blood transfusion in the past 6 months.  For women donors, it is important to ask history of pregnancy, any abortions in the last 3 months or children less than 1 yr old.
  • 13.
  • 14.  Helps to collect same information systematically from each donor.  Donor clinical staff does not forget to ask some important questions.  It helps donor clinic staff to make quick assessment whether to accept, temporarily defer or permanently reject the donor.
  • 15.  It is important to make preliminary health check up of the donor before donation, in order to make an assessment of their health status and not solely depend on what donors tell in their medical history.  The following parameters should be checked each time the donor comes to donate blood.
  • 16. General appearance The donor should be in good health Age Donors should be between the age of 18-60 years Weight Donors weighing 45 kg can give 350 ml of blood and those weighing 55 kg and above may give 450 ml of blood Blood pressure The systolic blood pressure should be between 100-180 mm Hg and diastolic blood pressure should be between 50-100 mm of Hg Pulse The pulse should be between 60-100 beats per minute and regular Temperature Oral temperature should not exceed 37.5°C Physical assessment of the donor Look for any skin rashes and swollen glands Scar of needle pricks at venipuncture site might indicate either drug addiction or frequent blood donations in professional donors Hemoglobin estimation Hb should not be less than 12.5 gm/dl
  • 17.  Heart disease  Kidney disease  Epilepsy  Anemia  Ulcers  Circulatory problems  Diabetes  Menstrual problems (excessive bleeding)  Pregnancy  Breast feeding
  • 18.  Similarly, it would be harmful for the recipient, if donor is having history of any of following diseases - • Hepatitis • Sexually transmitted disease • Recent vaccination • Active tuberculosis • Malaria • HIV/AIDS • Lung disease • Recent history of blood transfusion or surgery • Unexplained weight loss
  • 19. CONDITIONS FOR DEFERRAL PERIOD OF DEFERRAL History of blood transfusion 6 months Minor surgery 3 months Major surgery 6 months Alcoholism Till intoxicated Typhoid 6 months after recovery History of malaria & duly treated 3 months (endemic) 6 months (non endemic) History of hepatitis in family or close contact 6 months
  • 20. CONDITIONS FOR DEFERRAL PERIOD OF DEFERRAL Immunizations (cholera, typhoid, diphtheria, tetanus, plague, etc) 24 hours after symptom free Rabies vaccination 1 year after bite Acute nephritis 6 months after recovery Breast feeding 6 months after delivery Abortion 6 months Tattoo 6 months
  • 21. DRUGS PERIOD OF DEFERRAL Aspirin 36-48 hrs Isotretinoin 1 month after last dose Finasteride 1 month after last dose Acitretin 3 years after last dose Hepatitis B Ig 12 months Bovine insulin Permanent deferral
  • 22.  Antibiotics  Topical steroid preparations for skin lesions not present at venipuncture sites.  Blood pressure medications. However, donor should be free from side effects of anti- hypertensives, especially postural hypotension.  Bronchodilators and decongestants  Oral hypoglycemic agents  Oral contraceptives, mild analgesics, vitamins and replacement hormones.
  • 23. Hepatitis B vaccine 7 days Oral Typhoid, Oral Polio, Yellow Fever 2 weeks Chicken pox, MMR (measles, mumps, rubella) 4 weeks Smallpox At least 21 days
  • 24.  Cancer  Heart disease  Abnormal bleeding tendencies  Unexplained weight loss  Diabetes controlled on insulin  Hepatitis B infection  Chronic nephritis  Signs and symptoms suggestive of AIDS
  • 25.  Liver disease  Tuberculosis  Polycythemia Vera  Asthma  Epilepsy  Leprosy  Schizophrenia  Endocrine disorders
  • 26.  Finally I would like to conclude my presentation with a note that blood donation could give as well as take lives.  Hence it is essentially important to follow all the rules and precautions to ensure safety of both the donor and the recipient.  Also it is important that voluntary non remunerated blood donations should be promoted, accepted and practised for safe blood supply.